ARRIVENT BIOPHARMA INC (AVBP) Stock Analyst Ratings
NASDAQ:AVBP - Nasdaq - US04272N1028 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 87% to AVBP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 39.37. This target is 45.45% above the current price.
AVBP was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about AVBP.
In the previous month the buy percentage consensus was at a similar level.
AVBP was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-11 | Citigroup | Maintains | Buy -> Buy |
| 2024-09-10 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-09-10 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-09-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-15 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-02-20 | Goldman Sachs | Initiate | Buy |
| 2024-02-20 | Citigroup | Initiate | Buy |
| 2024-02-20 | Jefferies | Initiate | Buy |